• Ophthalmology Hospital of The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China;
Zhang Lu, Email: 13796089809@163.com
Export PDF Favorites Scan Get Citation

Age-related macular degeneration (AMD) is a multifactorial disease affected by environmental factors and genetic variation, which is a major cause of irreversible vision loss in the elderly. miRNA is a kind of endogenous non-coding RNA, which plays an important role in the pathogenesis of AMD, such as oxidative stress, pathological neovascularization and inflammation, by inhibiting or silencing the expression of transcription genes. miRNA has unique advantages in terms of ease synthesis, targeting and additive effect, a large number of experiments have proved the therapeutic potential of miRNA in AMD, which is expected to become a new method for the treatment of AMD in the future. Since the pathogenesis of AMD has not been fully elucidated, it is still necessary to continue to study the pathogenesis of AMD, the biological effects and mechanisms of various miRNA in the occurrence and development of AMD, and observe its therapeutic effects in AMD, so as to provide more effective options for the precise prevention and treatment of AMD.

Citation: Gao Jingfan, Zhang Lu. Research progress of miRNA in age-related macular degeneration. Chinese Journal of Ocular Fundus Diseases, 2021, 37(6): 488-491. doi: 10.3760/cma.j.cn511434-20200312-00109 Copy

  • Previous Article

    Advances in the application of optogenetic in the treatment of retinal degenerative diseases
  • Next Article

    Application progress of artificial intelligence in the screening of diabetic retinopathy